RT @FrontOncology: New research: Treatment with palbociclib and tislelizumab for CDKN2A-mutated and PD-L1-positive advanced intrahepatic ch…
266 followers
12,115 followers
RT @FrontOncology: New research: Treatment with palbociclib and tislelizumab for CDKN2A-mutated and PD-L1-positive advanced intrahepatic ch…
811 followers
RT @FrontOncology: New research: Treatment with palbociclib and tislelizumab for CDKN2A-mutated and PD-L1-positive advanced intrahepatic ch…
6,542 followers
New research: Treatment with palbociclib and tislelizumab for CDKN2A-mutated and PD-L1-positive advanced intrahepatic cholangiocarcinoma: a case report and literature review: Background Intrahepatic cholangiocarcinoma (ICC) is the second most… https://t.c